scispace - formally typeset
R

Raffaele Turano

Researcher at University of Brescia

Publications -  12
Citations -  459

Raffaele Turano is an academic researcher from University of Brescia. The author has contributed to research in topics: Nepafenac & Bromfenac. The author has an hindex of 8, co-authored 12 publications receiving 415 citations.

Papers
More filters
Journal ArticleDOI

Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.

TL;DR: Ginkgo biloba extract administration appears to improve preexisting visual field damage in some patients with NTG, and no significant changes were found in intraocular pressure, blood pressure, or heart rate after placebo or GBE treatment.
Journal ArticleDOI

Effects of Topical Hypotensive Drugs on Circadian IOP, Blood Pressure, and Calculated Diastolic Ocular Perfusion Pressure in Patients with Glaucoma

TL;DR: In this study of patients with newly diagnosed primary open-angle glaucoma, only dorzolamide and latanoprost significantly increased mean 24-hour DOPP, although timolol was as effective as latano during the daytime, and dorZolamide are as effective at night.
Journal ArticleDOI

Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Vertical Cup-to-Disc Ratio.

TL;DR: Smartphone ophthalmoscopy showed substantial agreement with slit-lamp examination for the estimation of the VCDR, enabling an extensive benefit for this technology to be used in glaucoma screening, especially in low-resource settings.
Journal ArticleDOI

Polymerase chain reaction as a rapid diagnostic tool for therapy of acute retinal necrosis syndrome

TL;DR: It is demonstrated that the use of PCR for detecting herpesvirus DNA in aqueous humor of uveitic subjects may be a valuable tool for early diagnosis of acute retinal necrosis syndrome and for timely administration of a suitable therapy.
Journal ArticleDOI

Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy

TL;DR: Both hd-PDT and 689-LT were effective at treating chronic CSC and both groups showed significant BCVA improvements, as well as reductions in central retinal and subfoveal choroidal thickness.